Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

Zidovudine - Generic Drug Details

« Back to Dashboard

What are the generic sources for zidovudine and what is the scope of freedom to operate?

is the generic ingredient in two branded drugs marketed by Viiv Hlthcare, Mylan Pharms Inc, Ranbaxy Labs Ltd, Aurobindo Pharma Ltd, Matrix Labs Ltd, Liaoning Chengda, West-ward Pharms Int, Cipla Ltd, Luitpold, Sunshine Lake, Cipla, Aurobindo, Hetero Labs Ltd Iii, and Aurobindo Pharma, and is included in nineteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for zidovudine. Eighteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: zidovudine

Drug Master File Entries: see list22
Suppliers / Packagers: see list18
Bulk Api Vendors: see list52
Clinical Trials: see list53
Patent Applications: see list4,287
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zidovudine at DailyMed

Tentative approvals for ZIDOVUDINE

Applicant Application No. Form Dosage
► Subscribe► SubscribeCAPSULE; ORAL100MG
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
INJECTABLE;INJECTION091457-001May 6, 2010APRXNoNo► Subscribe► Subscribe
Matrix Labs Ltd
TABLET;ORAL200732-001Feb 23, 2011DISCNNoNo► Subscribe► Subscribe
Sunshine Lake
TABLET;ORAL202058-001Oct 7, 2011DISCNNoNo► Subscribe► Subscribe
Viiv Hlthcare
TABLET;ORAL020518-001Dec 19, 1995DISCNNoNo► Subscribe► Subscribe
Hetero Labs Ltd Iii
TABLET;ORAL090092-001Apr 25, 2008ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus